KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
150 hedge funds and large institutions have $1.14B invested in Keryx Biopharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more call options, than puts
Call options by funds: $32.6M | Put options by funds: $29.1M
Holders
150
Holding in Top 10
7
Calls
$32.6M
Puts
$29.1M
Top Buyers
| 1 | +$108M | |
| 2 | +$35.2M | |
| 3 | +$28.3M | |
| 4 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$26M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$23M |
Top Sellers
| 1 | -$22M | |
| 2 | -$14.8M | |
| 3 | -$12M | |
| 4 |
D.E. Shaw & Co
New York
|
-$10.9M |
| 5 |
Goldman Sachs
New York
|
-$8.76M |